• Comprehensive molecular characterization of BCP lymphoblastic lymphoma allows molecular subtyping analogous to leukemias.

  • Compared with leukemias, lymphomas show more alterations in epigenetic modifiers and fewer in B-cell development genes.

Abstract

Pediatric B-cell precursor (BCP) lymphoblastic malignancies are neoplasms with manifestation either in the bone marrow or blood (BCP acute lymphoblastic leukemia [BCP-ALL]) or are less common in extramedullary tissue (BCP lymphoblastic lymphoma [BCP-LBL]). Although both presentations are similar in morphology and immunophenotype, molecular studies have been virtually restricted to BCP-ALL so far. The lack of molecular studies on BCP-LBL is due to its rarity and restriction on small, mostly formalin-fixed paraffin-embedded (FFPE) tissues. Here, to our knowledge, we present the first comprehensive mutational and transcriptional analysis of what we consider the largest BCP-LBL cohort described to date (n = 97). Whole-exome sequencing indicated a mutational spectrum of BCP-LBL, strikingly similar to that found in BCP-ALL. However, epigenetic modifiers were more frequently mutated in BCP-LBL, whereas BCP-ALL was more frequently affected by mutation in genes involved in B-cell development. Integrating copy number alterations, somatic mutations, and gene expression by RNA sequencing revealed that virtually all molecular subtypes originally defined in BCP-ALL are present in BCP-LBL, with only 7% of lymphomas that were not assigned to a subtype. Similar to BCP-ALL, the most frequent subtypes of BCP-LBL were high hyperdiploidy and ETV6::RUNX1. Tyrosine kinase/cytokine receptor rearrangements were detected in 7% of BCP-LBL. These results indicate that genetic subtypes can be identified in BCP-LBL using next-generation sequencing, even in FFPE tissue, and may be relevant to guide treatment.

1.
Alaggio
R
,
Amador
C
,
Anagnostopoulos
I
, et al
.
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
.
Leukemia
.
2022
;
36
(
7
):
1720
-
1748
.
2.
Kroeze
E
,
Arias Padilla
L
,
Bakker
M
, et al
.
Pediatric precursor B-cell lymphoblastic malignancies: from extramedullary to medullary involvement
.
Cancers
.
2022
;
14
(
16
):
3895
.
3.
Hunger
SP
,
Mullighan
CG
.
Acute lymphoblastic leukemia in children
.
N Engl J Med
.
2015
;
373
(
16
):
1541
-
1552
.
4.
Linabery
AM
,
Ross
JA
.
Trends in childhood cancer incidence in the U.S. (1992-2004)
.
Cancer
.
2008
;
112
(
2
):
416
-
432
.
5.
Reedijk
AMJ
,
Coebergh
JWW
,
de Groot-Kruseman
HA
, et al
.
Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015
.
Leukemia
.
2020
;
35
(
4
):
1001
-
1011
.
6.
Schwab
C
,
Harrison
CJ
.
Advances in B-cell precursor acute lymphoblastic leukemia genomics
.
Hemasphere
.
2018
;
2
(
4
):
e53
.
7.
Brady
SW
,
Roberts
KG
,
Gu
Z
, et al
.
The genomic landscape of pediatric acute lymphoblastic leukemia
.
Nat Genet
.
2022
;
54
(
9
):
1376
-
1389
.
8.
Schraders
M
,
van Reijmersdal
SV
,
Kamping
EJ
, et al
.
High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage
.
Cancer Genet Cytogenet
.
2009
;
191
(
1
):
27
-
33
.
9.
Sharma
R
,
Klairmont
MM
,
Holland
AC
, et al
.
Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21
.
Pediatr Blood Cancer
.
2020
;
67
(
9
):
e28357
.
10.
Knez
V
,
Bao
L
,
Carstens
B
,
Liang
X
.
Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood
.
Leuk Lymphoma
.
2020
;
61
(
9
):
2129
-
2135
.
11.
Kubota-Tanaka
M
,
Osumi
T
,
Miura
S
, et al
.
B-lymphoblastic lymphoma with TCF3-PBX1 fusion gene
.
Haematologica
.
2019
;
104
(
1
):
e35
-
e37
.
12.
Au-Yeung
RKH
,
Padilla
LA
,
Zimmermann
M
, et al
.
Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma
.
Leukemia
.
2023
;
37
(
2
):
488
-
491
.
13.
Casparie
M
,
Tiebosch
AT
,
Burger
G
, et al
.
Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive
.
Cell Oncol
.
2007
;
29
(
1
):
19
-
24
.
14.
Stewart
JP
,
Gazdova
J
,
Darzentas
N
, et al
.
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
.
Blood Adv
.
2021
;
5
(
16
):
3188
-
3198
.
15.
DePristo
MA
,
Banks
E
,
Poplin
R
, et al
.
A framework for variation discovery and genotyping using next-generation DNA sequencing data
.
Nat Genet
.
2011
;
43
(
5
):
491
-
498
.
16.
Wood
RD
,
Mitchell
M
,
Sgouros
J
,
Lindahl
T
.
Human DNA repair genes
.
Science
.
2001
;
291
(
5507
):
1284
-
1289
.
17.
Vaque
JP
,
Martinez
N
,
Batlle-Lopez
A
, et al
.
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies
.
Haematologica
.
2014
;
99
(
2
):
222
-
231
.
18.
Van der Auwera
GA
,
Carneiro
MO
,
Hartl
C
, et al
.
From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline
.
Curr Protoc Bioinformatics
.
2013
;
43
(
1110
):
11.10.1
-
11.10.33
.
19.
Dobin
A
,
Davis
CA
,
Schlesinger
F
, et al
.
STAR: ultrafast universal RNA-seq aligner
.
Bioinformatics
.
2013
;
29
(
1
):
15
-
21
.
20.
Uhrig
S
,
Ellermann
J
,
Walther
T
, et al
.
Accurate and efficient detection of gene fusions from RNA sequencing data
.
Genome Res
.
2021
;
31
(
3
):
448
-
460
.
21.
Beder
T
,
Hansen
BT
,
Hartmann
AM
, et al
.
The Gene Expression Classifier ALLCatchR identifies B-cell precursor ALL subtypes and underlying developmental trajectories across age
.
Hemasphere
.
2023
;
7
(
9
):
e939
.
22.
Burkhardt
B
,
Zimmermann
M
,
Oschlies
I
, et al
.
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence
.
Br J Haematol
.
2005
;
131
(
1
):
39
-
49
.
23.
Landmann
E
,
Burkhardt
B
,
Zimmermann
M
, et al
.
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma
.
Haematologica
.
2017
;
102
(
12
):
2086
-
2096
.
24.
Campo
E
,
Jaffe
ES
,
Cook
JR
, et al
.
The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee
.
Blood
.
2022
;
140
(
11
):
1229
-
1253
.
25.
Oschlies
I
,
Burkhardt
B
,
Chassagne-Clement
C
, et al
.
Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel
.
Am J Surg Pathol
.
2011
;
35
(
6
):
836
-
844
.
26.
Krangel
MS
.
Gene segment selection in V(D)J recombination: accessibility and beyond
.
Nat Immunol
.
2003
;
4
(
7
):
624
-
630
.
27.
Kotrova
M
,
Darzentas
N
,
Pott
C
,
Baldus
CD
,
Bruggemann
M
.
Immune gene rearrangements: unique signatures for tracing physiological lymphocytes and leukemic cells
.
Genes (Basel)
.
2021
;
12
(
7
):
979
.
28.
Szczepanski
T
,
Beishuizen
A
,
Pongers-Willemse
MJ
, et al
.
Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease
.
Leukemia
.
1999
;
13
(
2
):
196
-
205
.
29.
Saint Fleur-Lominy
S
,
Evensen
NA
,
Bhatla
T
, et al
.
Evolution of the epigenetic landscape in childhood B acute lymphoblastic leukemia and its role in drug resistance
.
Cancer Res
.
2020
;
80
(
23
):
5189
-
5202
.
30.
Gu
Z
,
Churchman
ML
,
Roberts
KG
, et al
.
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
.
Nat Genet
.
2019
;
51
(
2
):
296
-
307
.
31.
Maitra
A
,
McKenna
RW
,
Weinberg
AG
,
Schneider
NR
,
Kroft
SH
.
Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature
.
Am J Clin Pathol
.
2001
;
115
(
6
):
868
-
875
.
32.
Elitzur
S
,
Shiloh
R
,
Loeffen
J
, et al
.
ATM germline pathogenic variants affect treatment outcomes in children with acute lymphoblastic leukemia/lymphoma and ataxia telangiectasia [abstract]
.
Blood
.
2023
;
142
(
suppl 1
):
520
.
You do not currently have access to this content.
Sign in via your Institution